Vienna, Austria

Pär Comstedt

This inventor holds 6 USPTO granted patents and 3 published patent applications. Top assignee: Valneva Austria Gmbh. Active years: 2015-2025.

USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 6.8

ph-index = 4

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Pär Comstedt: Innovator in Biotechnology

Introduction

Pär Comstedt is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of innovative medical treatments. With a total of six patents to his name, Comstedt's work focuses on enhancing the efficacy of treatments for infections.

Latest Patents

Among his latest patents is a groundbreaking invention related to mutant fragments of outer surface protein A (OspA). This invention encompasses a polypeptide that includes a mutant fragment of OspA, along with a nucleic acid coding for the same. The patent also details a pharmaceutical composition intended for use as a medicament in treating or preventing infections. Furthermore, it outlines methods for immunizing subjects against such infections.

Career Highlights

Pär Comstedt is currently associated with Valneva Austria GmbH, where he continues to push the boundaries of medical research and innovation. His work has been instrumental in developing new therapeutic approaches that could significantly impact public health.

Collaborations

Comstedt collaborates with esteemed colleagues such as Markus Hanner and Urban Lundberg. Their combined expertise fosters a dynamic research environment that enhances the potential for groundbreaking discoveries.

Conclusion

Pär Comstedt's contributions to biotechnology and his innovative patents reflect his commitment to advancing medical science. His work not only showcases his inventive spirit but also holds promise for improving treatment options for infections.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…